 |
 |

Clinicopathologic Findings in the Bannayan-Riley-Ruvalcaba Syndrome
Maria Concetta Fargnoli, MD;
Seth J. Orlow, MD, PhD;
Jennifer Semel-Concepcion, MD;
Jean L. Bolognia, MD
Arch Dermatol. 1996;132(10):1214-1218.
Abstract
 |  |
Background The term Bannayan-Riley-Ruvalcaba syndrome has been proposed to reflect the clinical overlap of 3 conditions previously described as separate entities, each inherited in an autosomal dominant fashion. They are the Riley-Smith, Bannayan-Zonana, and Ruvalcaba-Myhre-Smith syndromes.
Observations We studied 2 kindreds with the Bannayan-Riley-Ruvalcaba syndrome. Characteristic cutaneous findings included multiple subcutaneous lipomas and vascular malformations, lentigines of the penis and vulva, verrucae, and acanthosis nigricans. Macrocephaly with normal ventricular size, mental retardation, central nervous system vascular malformations, intestinal polyposis, skeletal abnormalities, and thyroid tumors were the most common systemic features. A striking clinical finding in 1 patient was widespread verrucous changes of both lips that histologically showed epidermal hyperplasia with papillomatosis and hyperkeratosis. Biopsy specimens of facial papules demonstrated the histological features of both syringomas and trichilemmomas. Lentiginous hyperplasia of the epidermis with increased pigment in the basal layer and a slight increase in the number of melanocytes were seen in biopsy specimens of the penile lentigines.
Conclusions The histologic findings of both the facial lesions and the pigmented macules of the penis in the Bannayan-Riley-Ruvalcaba syndrome have not, to our knowledge, been reported previously. The similarities between the Bannayan-Riley-Ruvalcaba syndrome and Cowden disease raise the possibility of a common genetic pathogenesis for these 2 diseases.
Arch Dermatol. 1996;132:1214-1218
Author Affiliations
From the Department of Dermatology, Yale University School of Medicine, New Haven, Conn (Drs Fargnoli and Bolognia); Department of Dermatology, University of L'Aquila, L'Aquila, Italy (Dr Fargnoli); and Ronald O. Perelman Department of Dermatology and Department of Pediatrics, New York University Medical Center, New York, NY (Drs Orlow and Semel-Concepcion). Dr Fargnoli was a fellow in dermatology at Yale University.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Mucocutaneous Neuromas: An Underrecognized Manifestation of PTEN Hamartoma-Tumor Syndrome.
Schaffer et al.
Arch Dermatol 2006;142:625-632.
ABSTRACT
| FULL TEXT
Male breast cancer in Cowden syndrome patients with germline PTEN mutations
Fackenthal et al.
J. Med. Genet. 2001;38:159-164.
ABSTRACT
| FULL TEXT
The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome
PARISI et al.
J. Med. Genet. 2001;38:52-58.
FULL TEXT
Expression of the PTEN tumour suppressor protein during human development
Gimm et al.
Hum Mol Genet 2000;9:1633-1639.
ABSTRACT
| FULL TEXT
Mutational Spectra of PTEN/MMAC1 Gene: a Tumor Suppressor With Lipid Phosphatase Activity
Ali et al.
JNCI J Natl Cancer Inst 1999;91:1922-1932.
ABSTRACT
| FULL TEXT
Phenotypic findings of Cowden syndrome and Bannayan-Zonana syndrome in a family associated with a single germline mutation in PTEN
Çelebi et al.
J. Med. Genet. 1999;36:360-364.
ABSTRACT
| FULL TEXT
Carney Complex, Peutz-Jeghers Syndrome, Cowden Disease, and Bannayan-Zonana Syndrome Share Cutaneous and Endocrine Manifestations, But Not Genetic Loci
Stratakis et al.
J. Clin. Endocrinol. Metab. 1998;83:2972-2976.
ABSTRACT
| FULL TEXT
|